SCHEMBL1636635

SCHEMBL1636635

CCC(Cc1ccccc1C(=O)O)CC(CC)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 3/20 0.41
CLCN2 P51788 1/20 0.38
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.37
ALDH1A1 P00352 4/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 1/20 0.36
ALOX15 P16050 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP2C9 P11712 1/20 0.35
HIF1A Q16665 1/20 0.35
MAPT P10636 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
HTT P42858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27772890 0.83 FOLH1 (0.50) FOLH1CLCN2POLBTSHRALDH1A1
SCHEMBL29150532 0.83 FOLH1 (0.33) FOLH1POLBALDH1A1GAAKDM4E
SCHEMBL9805950 0.76 FOLH1 (0.49) FOLH1ALDH1A1LMNACA2KDM4E
SCHEMBL28215621 0.76 SLC6A2 (0.44) TSHRKDM4E
SCHEMBL31073993 0.75 ALDH1A1 (0.55) FOLH1CLCN2TSHRALDH1A1LMNA
SCHEMBL131266 0.75 ALDH1A1 (0.55) FOLH1CLCN2TSHRALDH1A1LMNA
SCHEMBL9724910 0.72 FOLH1 (0.49) FOLH1CLCN2POLBTSHRALDH1A1
SCHEMBL9724906 0.72 FOLH1 (0.49) FOLH1CLCN2POLBTSHRALDH1A1
SCHEMBL4668472 0.72 FOLH1 (0.44) FOLH1CLCN2POLBTSHRALDH1A1
SCHEMBL7102378 0.72 FOLH1 (0.48) FOLH1CLCN2POLBTSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1422563-B1 Method of forming a patterned film of surface-modified carbon nanotubes, surface-modified carbon nanotubes and a film comprising the same SAMSUNG ELECTRONICS CO LTD (KR) 2013-12-11 EP claimed
US-20260085194-A1 OPTICAL PRODUCT TOKYO OHKA KOGYO CO LTD (JP) 2026-03-26 US disclosed
US-12523930-B2 Nanoimprint composition and pattern forming method TOKYO OHKA KOGYO CO., LTD. (JP) 2026-01-13 US disclosed
US-20250333548-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO LTD (JP) 2025-10-30 US disclosed
US-12422749-B2 Photosensitive ink composition, cured product, display panel, and method for producing cured product TOKYO OHKA KOGYO CO., LTD. (JP) 2025-09-23 US disclosed
US-20250289926-A1 CURABLE COMPOSITION FOR INSULATING FILM FORMATION, INSULATING FILM FORMATION METHOD, AND TERMINALLY MALEIMIDE-MODIFIED POLYPHENYLENE ETHER RESIN TOKYO OHKA KOGYO CO LTD (JP) 2025-09-18 US disclosed
US-20250282900-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2025-09-11 US disclosed
US-12379664-B2 Photosensitive ink composition, cured product, display panel, and method for producing cured product TOKYO OHKA KOGYO CO., LTD. (JP) 2025-08-05 US disclosed
US-12312489-B2 Curable composition, cured product and method for forming insulating film TOKYO OHKA KOGYO CO., LTD. (JP) 2025-05-27 US disclosed
US-20250138421-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2025-05-01 US disclosed
US-20140030652-A1 PRIMER AND PATTERN FORMING METHOD FOR LAYER INCLUDING BLOCK COPOLYMER RIKEN (JP) 2014-01-30 US disclosed
CN-102464785-A Photocurable (alkyl) acrylate composition DAXIN MATERIALS CORP 2012-05-23 CN disclosed
US-7932221-B2 Solvent for cleaning TOKYO OHKA KOGYO CO., LTD. (JP) 2011-04-26 US disclosed
US-20090321693-A1 Red colored composition and color filter using the same TOPPAN PRINTING CO., LTD. (JP) 2009-12-31 US disclosed
US-20080039355-A1 Solvent for Cleaning TOKYO OHKA KOGYO CO., LTD. (JP) 2008-02-14 US disclosed
US-7229979-B2 Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents IMMUNE MODULATION, INC. (US) 2007-06-12 US disclosed
EP-1761258-A1 HYPOESTOXIDES, DERIVATIVES AND AGONISTS THEREOF FOR USE AS STENT-COATING AGENTS Paraquest, Inc. (US) 2007-03-14 EP disclosed
WO-2006007358-A1 HYPOESTOXIDES, DERIVATIVES ANS AGONISTS THEREOF FOR USE AS STENT-COATING AGENTS PARAQUEST, INC. (US) 2006-01-19 WO disclosed
US-20040258728-A1 Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents PARAQUEST MEDIVICE, INC. 2004-12-23 US disclosed
US-5908720-A CARBON BLACK COATED WITH A RESIN OBTAINED FROM ONE OR MORE POLYMERIZABLE MONOMERS HAVING AT LEAST ONE REACTIVE GROUP SELECTED FROM THE GROUP CONSISTING OF EPOXY, THIOEPOXY, OXAZOLINE, AZILIDINE AND HYDROXYALKYL AMIDE GROUPS TOKYO OHKA KOGYO CO., LTD. (JP) 1999-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085194-A1 OPTICAL PRODUCT PFN1, CFL1, C9 FOLH1 3754/4885CLCN2 1428/4885POLB 741/4885
US-20040258728-A1 Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents TBXA2R, THPO, BID FOLH1 588/4885CLCN2 4615/4885POLB 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.